title: Granulocyte colony-stimulating factor (G-CSF) could enhance Fcgamma receptor expression in neutrophils of patients with B-cell lymphoma treated with rituximab.
authors: Goro
authors: G
authors: Sashida
authors: Tomo-Iku
authors: TI
authors: Takaku
authors: Seiko
authors: S
authors: Honda
authors: Yuko
authors: Y
authors: Ishii
authors: Noritaka
authors: N
authors: Yamaguchi
authors: Masahiko
authors: M
authors: Sumi
authors: Nahoko
authors: N
authors: Shoji
authors: Akihiko
authors: A
authors: Gotoh
authors: Takashi
authors: T
authors: Shimamoto
authors: Yoshikazu
authors: Y
authors: Ito
authors: Kazuma
authors: K
authors: Ohyashiki
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004357:Drug Synergism; D005434:Flow Cytometry; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D016130:Immunophenotyping; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects*; D017452:Receptors, IgG / Q000096:biosynthesis*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D017452:Receptors, IgG; D016179:Granulocyte Colony-Stimulating Factor; D000069283:Rituximab